| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.048 | 0.7 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.015 | 0.8 |